The facility is anticipated to be ready for licensing and production before the end of 2017.

Canopy Growth announced the acquisition of Spot Therapeutics, an ACMPR applicant based in Fredericton, New Brunswick. 

Additionally, through an affiliated entity, the company has entered a definitive agreement to complete the previously announced purchase of the industrial building and property where its production and distribution platform is being established.

These strategic acquisitions solidify Canopy Growth's commitment to expand operations into New Brunswick with a large-scale indoor production facility both quickly, and cost efficiently.

Click here to read the complete article 

Technical420.com via 420Intel.com ~